Classically, basic cardiovascular research has been delimited to investigating one of the two architectural territories of the heart; the myocardium and the coronary vasculature. Technological advances continue to foster mechanistic insights on homeostatic physiology and pathophysiology of the heart. In parallel, translational efforts in gene therapy1 and stem cell biology2 have exploited newly-gained concepts toward creating disease-modifying activities in animal models and clinical trials. Together, these advances have blurred the structural boundaries between the myocardium and the circulation, and brought us to appreciate the key signaling pathways that are common to various domains of the heart as well as the fluidity of molecular signals that play opposing roles depending on the spatial and temporal context.
In this thematic series, four review articles bring spotlights on key conceptual advances in the cardiovascular research. It opens with Kwong and colleagues’ article on mitochondrial metabolism, and strategies to target specifically the mitochondrial reactive oxygen species for better therapeutic outcomes. De Couto connects cardiac regeneration/repair with one of the most dynamic cell types within the heart, the macrophages, and presents approaches to modulating the immune cells’ properties with extracellular vesicles. Kassiri and colleagues highlight the significance of the extracellular milieu in the context of aortic aneurism, and the importance of choosing the correct model to study specific matrix. Finally, Eom and Yoon bring together the molecular concepts and present the-state-of-the art in understanding an elusive form of heart failure that appears to be normal in its ability to pump blood effectively. All four articles underscore topics that are highly relevant now. A quick search on PubMed illustrate nearly an exponential increase in the number of peer-reviewed articles published in recent years on each topic (Fig. 1). What ties the four articles together is the aforementioned idea; understanding principal components of mitochondrial metabolism, macrophage modulation, and extracellular matrix will be key to developing therapeutic approaches to a complex disease such as heart failure.
References
Ishikawa, K., Weber, T. & Hajjar, R. J. Human cardiac gene therapy. Circ. Res 123, 601–613 (2018).
Rosen, M. R., Myerburg, R. J., Francis, D. P., Cole, G. D. & Marban, E. Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J. Am. Coll. Cardiol. 64, 922–937 (2014).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kook, H., Cho, H.C. Spotlight on recent advances in cardiovascular biology. Exp Mol Med 51, 1–2 (2019). https://doi.org/10.1038/s12276-019-0354-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s12276-019-0354-8